Keyphrases
T Cells
100%
Tumor
100%
Chimeric Antigen Receptor T Cells (CAR-T)
100%
Antitumor
33%
Natural Killer Cells
33%
Melanoma Patients
33%
Cancer Treatment
16%
TNF-α Secretion
16%
Interferon-γ
16%
Flow Cytometry
16%
Malignancy
16%
Solid Tumors
16%
Antitumor Activity
16%
NKp46
16%
Colon Cancer
16%
Breast Cancer
16%
Lung Cancer
16%
Natural Killer
16%
Relative Expression
16%
Leukemia
16%
Cervical Carcinoma
16%
Genetic Modification
16%
Liver Cancer
16%
Histology
16%
Extracellular Domain
16%
Tumor Response
16%
Cervical Cancer
16%
CD69
16%
CD25
16%
Tumor Recognition
16%
NKp30
16%
Surface Markers
16%
Cytotoxicity Assay
16%
Xenograft Tumor
16%
Efficient Recognition
16%
Hepatocarcinoma
16%
Adoptive Cell Transfer
16%
4-1BB
16%
Tumor Receptors
16%
Cervical Melanoma
16%
In Ovo
16%
Medicine and Dentistry
Receptor
100%
Neoplasm
100%
T Lymphocyte
100%
Melanoma
37%
Natural Killer Cell
25%
In Vitro
12%
Tumor Necrosis Factor
12%
T Cell
12%
Flow Cytometry
12%
Cancer
12%
Secretion (Process)
12%
Antineoplastic Activity
12%
Breast Cancer
12%
Tumor Xenograft
12%
Leukemia
12%
Solid Malignant Neoplasm
12%
Cancer Treatment
12%
Colon Carcinoma
12%
Uterine Cervix Carcinoma
12%
Liver Cancer
12%
Lung Cancer
12%
Hepatocellular Carcinoma
12%
Cervical Cancer
12%
Cytotoxicity Assay
12%
Transfer Cell
12%
Pharmacology, Toxicology and Pharmaceutical Science
Receptor
100%
Neoplasm
100%
Melanoma
33%
Tumor Necrosis Factor
11%
Flow Cytometry
11%
Malignant Neoplasm
11%
Solid Malignant Neoplasm
11%
Breast Cancer
11%
Lung Cancer
11%
Leukemia
11%
Antitumor Activity
11%
Liver Cell Carcinoma
11%
Liver Cancer
11%
Uterine Cervix Cancer
11%
Colon Carcinoma
11%
Uterine Cervix Carcinoma
11%
Cytotoxicity Assay
11%
Immunology and Microbiology
T Cell
100%
Natural Killer Cell
33%
Colon
16%
Secretion (Process)
16%
Cytotoxicity
16%
Xenograft
16%
Antineoplastic Activity
16%
Tumor Necrosis Factor Alpha
16%
DNA Modification
16%
CD69
16%
CD25
16%
Transfer Cell
16%
In Ovo
16%